Your browser doesn't support javascript.
loading
Pigment Epithelium-Derived Factor Peptide Promotes Corneal Nerve Regeneration: An In Vivo and In Vitro Study.
Yeh, Shu-I; Yu, Sung-Hsun; Chu, Hsiao-Sang; Huang, Chin-Te; Tsao, Yeou-Ping; Cheng, Chao-Min; Chen, Wei-Li.
Afiliação
  • Yeh SI; Department of Ophthalmology, Mackay Memorial Hospital, Taipei, Taiwan.
  • Yu SH; Department of Medicine, Mackay Medical College, New Taipei City, Taiwan.
  • Chu HS; Department of Ophthalmology, National Taiwan University Hospital, Taipei, Taiwan.
  • Huang CT; Advanced Ocular Surface and Corneal Nerve Research Center, National Taiwan University, Taipei, Taiwan.
  • Tsao YP; Department of Ophthalmology, National Taiwan University Hospital, Taipei, Taiwan.
  • Cheng CM; Advanced Ocular Surface and Corneal Nerve Research Center, National Taiwan University, Taipei, Taiwan.
  • Chen WL; Department of Ophthalmology, National Taiwan University Hospital, Taipei, Taiwan.
Invest Ophthalmol Vis Sci ; 62(1): 23, 2021 01 04.
Article em En | MEDLINE | ID: mdl-33481984
Purpose: To investigate the potential of a pigment epithelium-derived factor (PEDF) peptide 44-mer to promote nerve regeneration in a rabbit corneal nerve injury model to demonstrate its neurotrophic ability in cultivated mouse trigeminal neuron cells. Methods: Subconjunctival or intrastromal injection of 44-mer on the cornea was performed in a rabbit model of corneal nerve injury created by corneal epithelial debridement. Immunocytochemical analysis (44-mer, anti-tubulin III, SMI312, CD11b, and α-SMA) and in vivo confocal microscopy were performed. Corneal sensation was estimated using a Cochet-Bonnet corneal esthesiometer. Primary cultivated mouse trigeminal neurons were used to examine the in vitro neurotrophic ability of 44-mer. The cellular morphology and the immunocytochemical staining with anti-tubulin III and SMI312 in different concentrations of 44-mer were compared, and a quantitative assessment of neurite outgrowth was performed. Results: Immunohistochemical staining showed the retention of 44-mer in the corneal stroma for at least 7 days after a single dose of corneal intrastromal injection and promoted corneal nerve regeneration revealed by in vivo confocal microscopy. Corneal esthesiometer demonstrated gradual recovery of the corneal sensation in 44-mer-treated eyes with a lower corneal touch threshold than wounded vehicles and closer to baseline at 3 weeks after corneal injury (P < 0.001). In vitro studies showed a dose-dependent neurotrophic effect of 44-mer in cultivated trigeminal neuron cells. Conclusions: The 44-mer showed in vivo and in vitro corneal neurotrophic abilities. Our results suggest that intrastromal injection of 44-mer into the corneal stroma may have a potential role in treating diseases related to corneal nerve damage.
Assuntos

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Nervo Oftálmico / Inibidores de Proteases / Serpinas / Córnea / Proteínas do Olho / Lesões da Córnea / Fatores de Crescimento Neural / Regeneração Nervosa Tipo de estudo: Prognostic_studies Limite: Animals Idioma: En Ano de publicação: 2021 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Nervo Oftálmico / Inibidores de Proteases / Serpinas / Córnea / Proteínas do Olho / Lesões da Córnea / Fatores de Crescimento Neural / Regeneração Nervosa Tipo de estudo: Prognostic_studies Limite: Animals Idioma: En Ano de publicação: 2021 Tipo de documento: Article